{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:58:01Z","timestamp":1790611081279,"version":"4.1.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"abstract":"<jats:p>This cohort study examines trends in dexmedetomidine administration and intensive care unit (ICU) admissions between 2020 and 2025 among hospitalized patients with opioid use disorder in Philadelphia, Pennsylvania.<\/jats:p>","DOI":"10.1001\/jamainternmed.2026.4568","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:30:25Z","timestamp":1790609425000},"source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine Use and Intensive Care Unit Admissions for Patients With Medetomidine Withdrawal"],"prefix":"10.1001","author":[{"given":"Tyler G.","family":"Boyce","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish P.","family":"Thakrar","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Center for Studies of Addiction, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Center for Addiction Medicine and Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget R.","family":"Durkin","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Center for Addiction Medicine and Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Casey","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine and Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Center for Addiction Medicine and Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"17","key":"ild260022r3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jama.2024.15992","article-title":"Medetomidine infiltrates the US illicit opioid market.","volume":"332","author":"Palamar","year":"2024","journal-title":"JAMA"},{"issue":"15","key":"ild260022r5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.15585\/mmwr.mm7415a2","article-title":"Notes from the field: suspected medetomidine withdrawal syndrome among fentanyl-exposed patients\u2014Philadelphia, Pennsylvania, September 2024\u2013January 2025.","volume":"74","author":"Huo","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"ild260022r6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.annemergmed.2025.12.004","article-title":"Emergence of medetomidine in the illicit drug supply: implications for emergency care and withdrawal management.","volume":"87","author":"Lynch","year":"2026","journal-title":"Ann Emerg Med"},{"issue":"23","key":"ild260022r10","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1001\/jama.2023.21288","article-title":"Trends in before medically advised discharges for patients with opioid use disorder, 2016-2020.","volume":"330","author":"Thakrar","year":"2023","journal-title":"JAMA"},{"key":"ild260022r8"},{"key":"ild260022r1","unstructured":"Medetomidine in the U.S. illegal fentanyl supply increasing risk for overdose and severe withdrawal syndrome. Centers for Disease Control and Prevention Health Alert Network. April 2, 2026. Accessed April 12, 2026. https:\/\/www.cdc.gov\/han\/php\/notices\/han00527.html"},{"key":"ild260022r2","unstructured":"Health Alert: Hospitals and behavioral health providers are reporting severe and worsening presentations of withdrawal among people who use drugs (PWUD) in Philadelphia. Philadelphia Department of Public Health Division of Substance Use Prevention and Harm Reduction. December 10, 2024. Accessed December 31, 2025. https:\/\/hip.phila.gov\/document\/4874\/PDPH-HAN-00444A-12-10-2024.pdf"},{"key":"ild260022r4","unstructured":"Health Alert: In Philadelphia, medetomidine, a potent non-opioid veterinary sedative, has been detected in the illicit drug supply. Philadelphia Department of Public Health Division of Substance Use Prevention and Harm Reduction. May 13, 2024. Accessed December 31, 2025. https:\/\/hip.phila.gov\/document\/4421\/PDPH-HAN-0441A-05-13-24.pdf"},{"key":"ild260022r7","unstructured":"Clinical Classifications Software Refined. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project. November 19, 2025. Accessed April 10, 2026. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp"},{"key":"ild260022r9","unstructured":"DeBord? JS, Laurano? R, Esteves Camacho? T, . NPS Discovery Q4 2025 Mid-Atlantic Drug Checking Quarterly Report. Center for Forensic Science Research and Education. 2026. Accessed April 13, 2026. https:\/\/www.cfsre.org\/images\/content\/reports\/drug_checking\/2025_Q4_Drug_Checking_Quarterly_Report_CFSRE_NPS_Discovery.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2854606\/jamainternal_boyce_2026_ld_260022_1790087535.73042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:30:29Z","timestamp":1790609429000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2854606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.4568","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}